Taken together, the measurements of P1NP, IL-6 or M2BPGi along with the basic chemistry tests would help determine the stage of NAFLD they correspond to at the time of initial diagnosis and predict responsiveness after the treatment. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.